Gapping down
In reaction to disappointing earnings/guidance:
- HAS -7.9%, HNI -3.2%, UBS -2.8%, SALT -1.4%
M&A news:
- AKRX -32.3% (Fresenius (FSNUY) to terminate merger agreement with Akorn due to Akorn's failure to fulfill several closing conditions)
- FMS -4% (to divest its controlling interest in Sound Inpatient Physicians for $2.15 bln, gives prelim Q1 results)
Select metals/mining stocks trading lower:
- EXK -5.9%, SVM -1.7%, GFI -1%, GOLD -0.8%, ABX -0.5%
Other news:
- PTN -9% (entered into $25 mln equity distribution agreement with Canaccord Genuity)
- KMDA -3.3% (receives feedback from FDA on proposed Phase 3 protocol for Inhaled Alpha-1-Antitrypsin .
Analyst comments:
- ARNC -1.1% (downgraded to Neutral from Buy at Longbow)
- PIR -1.1% (downgraded to Underperform from Mkt Perform at Raymond James)
- LULU -1.6% (downgraded to Hold from Buy at Needham)
- OAS -4% (downgraded to Sell from Hold at SunTrust)
- SPWR -6.6% (downgraded to Underperform from Neutral at BofA/Merrill)
